HLA class-I genotyping to personalize Bacille Calmette–Guerin immunotherapy in bladder cancer

Inmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, Pedro López Cubillana, Tomás Fernández Aparicio, Lucas Jesús Asensio Egea, Juan Moreno Avilés, Gloria Doñate Iñiguez, Pablo Luis Guzmán Martínez-Valls, Gerardo Server, Belén Ferri, José Antonio Campillo, Francisco Galindo, María Victoria Ma · 2025

Read HLA class-I genotyping to personalize Bacille Calmette–Guerin immunotherapy in bladder cancer by Inmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, Pedro López Cubillana, Tomás Fernández Aparicio, Lucas Jesús Asensio Egea, Juan Moreno Avilés, Gloria Doñate Iñiguez, Pablo Luis Guzmán Martínez-Valls, Gerardo Server, Belén Ferri, José Antonio Campillo, Francisco Galindo, María Victoria Ma (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12710922.txt.

Description

Ruiz-Lorente and co-authors test whether HLA gene typing can predict who benefits from BCG therapy for bladder cancer. BCG is the top immune therapy for high-risk, early bladder cancer. Yet half of patients see the cancer return, and twenty percent progress.

The team typed HLA class-I genes in 325 bladder cancer patients at diagnosis. Of those, 151 got BCG and 174 got other care, with large control groups for scale. Certain types, such as HLA-A*11 and HLA-B*07, linked to better survival after BCG. Others, such as HLA-B*44, linked to worse outcomes.

Catalog record

CREATORInmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, Pedro López Cubillana, Tomás Fernández Aparicio, Lucas Jesús Asensio Egea, Juan Moreno Avilés, Gloria Doñate Iñiguez, Pablo Luis Guzmán Martínez-Valls, Gerardo Server, Belén Ferri, José Antonio Campillo, Francisco Galindo, María Victoria Ma
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12710922

Browse the full library · About the Tower of Babel